Drugs Currently Undergoing Preclinical or Clinical Trials for the Treatment of Overactive Bladder: A Review

Drugs Currently Undergoing Preclinical or Clinical Trials for the Treatment of Overactive Bladder: A Review

ABSTRACT: Background: Overactive bladder (OAB) is a common clinical condition for which current drug treatment comprises drugs blocking the cholinergic nerve supply, or augmenting the adrenergic nerve supply, to the detrusor muscle of the urinary bladder. Current treatments have drawbacks, includin...

Full description

Bibliographic Details
Main Authors:	Silvia Joseph, MBBS, Steffi A. Maria, MD, Jacob Peedicayil, MD
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Current Therapeutic Research
Subjects:	contractility detrusor new drugs overactive bladder pharmacodynamics
Online Access:	http://www.sciencedirect.com/science/article/pii/S0011393X2200008X

Similar Items

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
by: Mohammed A. Al-Ghazo, et al.
Published: (2011-03-01)

Botulinum toxin A for the Treatment of Overactive Bladder
by: Po-Fan Hsieh, et al.
Published: (2016-02-01)

Cerebellar Ataxia and Overactive Bladder after Encephalitis Affecting the Cerebellum
by: Megumi Sugiyama, et al.
Published: (2009-07-01)

Bladder contractility index changes with short-term antimuscarinic therapy in patients with detrusor overactivity: A placebo controlled randomised study
by: Alka Ashok Bhide, et al.
Published: (2023-12-01)

The use of botulinum toxin for the treatment of overactive bladder syndrome
by: Bogdan Orasanu, et al.
Published: (2013-01-01)

FREQUENCY OF DETRUSOR LEAK POINT PRESSURES AMONGST PATIENTS WITH URODYNAMIC DIAGNOSIS OF DETRUSOR OVERACTIVITY
by: Nadeem Ahmad, et al.
Published: (2019-08-01)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
by: Aida Javan Balegh Marand, et al.
Published: (2023-05-01)

Effectiveness and Safety of Intradetrusor OnabotulinumtoxinA Injection for Neurogenic Detrusor Overactivity and Overactive Bladder Patients in Taiwan—A Phase IV Prospective, Interventional, Multiple-Center Study (Restore Study)
by: Chung-Cheng Wang, et al.
Published: (2021-12-01)

Inhibition of Contractility of Isolated Caprine Detrusor by the Calcium Channel Blocker Cilnidipine and Reversal by Calcium Channel Openers
by: Steffi A. Maria, MD, et al.
Published: (2023-01-01)

Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease
by: Gregory Vurture, et al.
Published: (2019-09-01)

The use of ultrasound-estimated bladder weight in diagnosing bladder outlet obstruction and detrusor overactivity in men with lower urinary tract symptoms
by: Fadi Housami, et al.
Published: (2009-01-01)

Surgical Outcomes and Predictive Factors in Patients With Detrusor Underactivity Undergoing Bladder Outlet Obstruction Surgery
by: Ming-Syun Chuang, et al.
Published: (2024-03-01)

Long term safety outcomes and continuation rates of repeated Intravesical Botulinum Toxin A injections for Detrusor Overactivity: 16 year’s experience of a Tertiary Centre in the UK
by: R. Mohamed-Ahmed, et al.
Published: (2024-03-01)

Urinary Nerve Growth Factor Levels in Overactive Bladder Syndrome and Lower Urinary Tract Disorders
by: Hsin-Tzu Liu, et al.
Published: (2010-12-01)

Low-count bacteriuria in refractory idiopathic detrusor overactivity versus controls
by: Colin Walsh, et al.
Published: (2011-07-01)

Low dose intradetrusor injections of onabotulinumtoxinA in women with overactive bladder symptoms or the painful bladder syndrome: unfavorable balance between clinical efficacy and the need for catheterization
by: Jan Groen, et al.
Published: (2012-10-01)

Hyperactive bladder: concept of disease and paradigms in the treatment
by: G. G. Krivoborodov, et al.
Published: (2021-04-01)

Short-term outcome of onabotulinumtoxin A injection for the treatment of refractory idiopathic detrusor overactivity
by: Gamal E A. Abourjila, et al.
Published: (2020-01-01)

Detrusor Overactivity After Partial Bladder Outlet Obstruction Is Associated With High Urinary Adenosine Triphosphate Levels in Female Wistar Rats
by: Luís Vale, et al.
Published: (2024-02-01)

Prevalence and urodynamic characteristics of detrusor overactivity with impaired contractility in the community-dwelling elderly with non-neurogenic lower urinary tract symptoms: Is it from a single or two independent bladder dysfunctions?
by: Seong Jin Jeong, et al.
Published: (2021-07-01)

Urine Nerve Growth Factor May Not Be Useful as a Biomarker of Overactive Bladder in Patients with Pelvic Organ Prolapse
by: Katarzyna Jankiewicz, et al.
Published: (2022-02-01)

Trigonal-Sparing vs. Trigonal-Involved OnabotulinumtoxinA Injection for the Treatment of Overactive Bladder: A Systematic Review and Meta-Analysis
by: Yuanshan Cui, et al.
Published: (2021-10-01)

Low dose intradetrusor injections of onabotulinumtoxina in women with overactive bladder symptoms or the painful bladder syndrome: unfavourable balance between clinical efficacy and the need for catheterisation
by: Jan Groen, et al.
Published: (2012-01-01)

Bladder ultrasonography for diagnosing detrusor overactivity: test accuracy study and economic evaluation
by: Suneetha Rachaneni, et al.
Published: (2016-01-01)

Role of percutaneous tibial nerve stimulation in the management of the detrusor overactivity
by: Emad K El Tair, et al.
Published: (2022-01-01)

Changing concepts in the diagnosis and management of overactive bladder
by: Hari Siva Gurunadha Rao Tunuguntla, et al.
Published: (2001-01-01)

Factors Influencing Postoperative Overactive Bladder after Adjustable Trans-Obturator Male System Implantation for Male Stress Incontinence following Prostatectomy
by: Miguel Virseda-Chamorro, et al.
Published: (2023-12-01)

Effects of a combination of herbal extracts (modified Ojayeonjonghwan (Wuzi Yanzong wan)) on partial urethral obstruction-induced detrusor overactivity in rats: impact on the nitric oxide pathway and oxidative stress
by: Sangrak Bae, et al.
Published: (2019-03-01)

Effect of Memantine on Overactive Detrusor in Rats With Spinal Cord Injury
by: Cüneyd Özkürkçügil, et al.
Published: (2010-05-01)

Re: Bhide AA et al. Bladder contractility index changes with short-term antimuscarinic therapy in patients with detrusor overactivity: A placebo controlled randomised study. Continence 8 (2023) 101047
by: Juan Pablo Valdevenito, et al.
Published: (2024-03-01)

Molecular Mechanism Operating in Animal Models of Neurogenic Detrusor Overactivity: A Systematic Review Focusing on Bladder Dysfunction of Neurogenic Origin
by: Ana Ferreira, et al.
Published: (2023-02-01)

Meta-Analysis of Randomized Controlled Trials Using Botulinum Toxin A at Different Dosages for Urinary Incontinence in Patients With Overactive Bladder
by: Qin-Qin Gong, et al.
Published: (2020-01-01)

Will repeated botulinum toxin A improve detrusor overactivity and bladder compliance in patients with chronic spinal cord injury?
by: Sheng-Fu Chen, et al.
Published: (2021-01-01)

Coexistent Detrusor Overactivity-Underactivity in Patients with Pelvic Floor Disorders
by: Matteo Frigerio, et al.
Published: (2022-09-01)

Investigating Urine Biomarkers in Detrusor Underactivity and Detrusor Overactivity with Detrusor Underactivity Patients
by: Yuan-Hong Jiang, et al.
Published: (2023-04-01)

Adipose-Derived Stem Cells and Their Derived Microvesicles Ameliorate Detrusor Overactivity Secondary to Bilateral Partial Iliac Arterial Occlusion-Induced Bladder Ischemia
by: Bing-Juin Chiang, et al.
Published: (2021-06-01)

Long-Term Effects of Percutaneous Tibial Nerve Stimulation Treatment for Neurogenic Overactive Bladder Due to Multiple Sclerosis: 24-Month Results
by: Mehmet Sevim, et al.
Published: (2023-01-01)

Definition and symptoms of underactive bladder
by: Alan D. Uren, et al.
Published: (2017-12-01)

Patient treatment preferences for symptomatic refractory urodynamic idiopathic detrusor overactivity
by: Christina L Fontaine, et al.
Published: (2017-01-01)

Long-term Outcome of Infants with Spina Bifida Through Assessment of the Prognostic Value of Hostile Bladder Parameters
by: Ali Tekin, et al.
Published: (2021-06-01)